New York State Common Retirement Fund’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

New York State Common Retirement Fund’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,500	Closed	-$17K	–	3306
2020 Q1	$17K	Hold	4,500	–	–	﹤0.01%	3117
2019 Q4	$27K	Sell	4,500 -16,800	-79%	-$115K	﹤0.01%	3162
2019 Q3	$161K	Hold	21,300	–	–	﹤0.01%	2869
2019 Q2	$289K	Buy	+21,300	New	+$246K	﹤0.01%	2642
2018 Q2	–	Sell	-12,200	Closed	-$106K	–	3235
2018 Q1	$106K	Hold	12,200	–	–	﹤0.01%	2943
2017 Q4	$153K	Hold	12,200	–	–	﹤0.01%	2869
2017 Q3	$102K	Hold	12,200	–	–	﹤0.01%	3000
2017 Q2	$207K	Buy	+12,200	New	+$243K	﹤0.01%	2827
2016 Q3	–	Sell	-1,800	Closed	-$12K	–	3172
2016 Q2	$12K	Sell	1,800 -4,200	-70%	-$35.1K	﹤0.01%	3167
2016 Q1	$57K	Hold	6,000	–	–	﹤0.01%	3034
2015 Q4	$60K	Buy	+6,000	New	+$79.4K	﹤0.01%	3091

Other funds holding ZYNE

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

ZCA

Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

New York State Common Retirement Fund's ZYNE Position: Q2 2020 in Review

New York State Common Retirement Fund sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q2 2020, closing a stake of 4,500 shares — an estimated $17K sold.

New York State Common Retirement Fund first reported a position in ZYNE in Q4 2015 and held it in 11 quarters. The position peaked at $289K in Q2 2019. 74 funds tracked by Wall St. Rank hold ZYNE as of Q2 2020.

New York State Common Retirement Fund reported no remaining Zynerba Pharmaceuticals, Inc position as of Q2 2020 after selling out during the quarter.
New York State Common Retirement Fund sold 4,500 Zynerba Pharmaceuticals, Inc shares in Q2 2020, an estimated $17K.
New York State Common Retirement Fund first reported a position in Zynerba Pharmaceuticals, Inc in Q4 2015 and held it in 11 quarters.
New York State Common Retirement Fund's Zynerba Pharmaceuticals, Inc position peaked at $289K in Q2 2019.
74 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q2 2020.

Based on New York State Common Retirement Fund's 13F filing for Q2 2020, filed 7 Aug 2020.